Skip to main content
. 2016 Feb 9;18(4):401–409. doi: 10.1111/dom.12626

Figure 2.

DOM-12626-FIG-0002-c

(A) Time (in years) from initiation of basal insulin therapy to intensification with bolus or premix insulin, or glucagon‐like peptide‐1(GLP‐1) in clinically eligible patients [glycated haemoglobin (HbA1c) ≥7.5% (58 mmol/mol)]. (B) Effect of covariates on time to intensification in clinically eligible patients [HbA1c ≥7.5% (58 mmol/mol), occurring at least 6 months after initiating basal insulin]. BMI, body mass index; CI, confidence interval; HR, hazard ratio; OHA, oral hypoglycaemic agent; y, years.